Trial intelligence / Profile preview

Effect of Liraglutide on Epicardial Fat in Type 2 Diabetes

NCT02014740Phase 4Completed

Sponsor
University of Miami
Start
Mar 2014
Primary completion
Mar 2017
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by University of Miami. Started Mar 2014; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02014740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02014740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call